Theraclion Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
34
- Stock Symbol
-
ALTHE
- Investments
-
1
- Share Price
-
$0.66
- (As of Friday Closing)
Theraclion General Information
Description
Theraclion specializes in developing, manufacturing, and marketing echotherapy equipment, associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules. Its products include Sonovein, Echopulse, and Epack.
Contact Information
Website
www.theraclion.comCorporate Office
- 244, avenue Pierre Brossolette
- 92240 Malakoff
- France
Corporate Office
- 244, avenue Pierre Brossolette
- 92240 Malakoff
- France
Theraclion Stock Performance
As of 13-Nov-2026, Theraclion’s stock price is $0.66. Its current market cap is $48.4M with 73.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.66 | $0.70 | $0.46 - $1.08 | $48.4M | 73.8M | 106K | -$0.11 |
Theraclion Financials Summary
As of 30-Jun-2026, Theraclion has a trailing 12-month revenue of $1.18M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 54,201 | 41,727 | 11,284 | 11,382 |
| Revenue | 1,183 | 1,338 | 898 | 1,972 |
| EBITDA | (6,999) | (6,761) | (7,021) | (4,889) |
| Net Income | (7,883) | (6,418) | (6,230) | (3,977) |
| Total Assets | 16,900 | 17,492 | 11,931 | 20,631 |
| Total Debt | 5,649 | 5,803 | 1,349 | 2,156 |
Theraclion Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Theraclion Comparisons
Industry
Financing
Details
Theraclion Competitors (25)
One of Theraclion’s 25 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| HistoSonics | Private Equity-Backed | Plymouth, MN | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| CooperSurgical | Corporate Backed or Acquired | Trumbull, CT | ||||
| Ulthera | Formerly VC-backed | Mesa, AZ |
Theraclion Patents
Theraclion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4778571-A1 | A hitu device | Pending | 21-Jan-2025 | ||
| EP-4778572-A1 | A hitu device | Pending | 21-Jan-2025 | ||
| WO-2026159062-A1 | A hitu device | Pending | 21-Jan-2025 | ||
| WO-2026159070-A1 | A hitu device and associated methods | Pending | 21-Jan-2025 | ||
| EP-4454586-A1 | System for gathering treatment data and/or generating a treatment plan for treating a patient with hitu and method for defining treatment parameters | Inactive | 26-Apr-2023 | A61B90/37 |
Theraclion Signals
Theraclion Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Theraclion Investments (1)
Theraclion’s most recent deal was a Joint Venture with Theraclion China. The deal was made on 24-Apr-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Theraclion China | 24-Apr-2017 | Joint Venture | Surgical Devices |
Theraclion ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Theraclion FAQs
-
When was Theraclion founded?
Theraclion was founded in 2004.
-
Where is Theraclion headquartered?
Theraclion is headquartered in Malakoff, France.
-
What is the size of Theraclion?
Theraclion has 34 total employees.
-
What industry is Theraclion in?
Theraclion’s primary industry is Therapeutic Devices.
-
Is Theraclion a private or public company?
Theraclion is a Public company.
-
What is Theraclion’s stock symbol?
The ticker symbol for Theraclion is ALTHE.
-
What is the current stock price of Theraclion?
As of 13-Nov-2026 the stock price of Theraclion is $0.66.
-
What is the current market cap of Theraclion?
The current market capitalization of Theraclion is $48.4M.
-
What is Theraclion’s current revenue?
The trailing twelve month revenue for Theraclion is $1.18M.
-
Who are Theraclion’s competitors?
Globus Medical, HistoSonics, Boston Scientific, CooperSurgical, and Ulthera are some of the 25 competitors of Theraclion.
-
What is Theraclion’s annual earnings per share (EPS)?
Theraclion’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process